These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16397211)

  • 61. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
    Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
    [TBL] [Abstract][Full Text] [Related]  

  • 62. HER-2/neu oncogene expression, DNA ploidy and proliferation index in breast cancer.
    Bacus SS; Chin DM; Stern RK; Ortiz R; Ruby SG; Weinberg DS
    Anal Quant Cytol Histol; 1992 Dec; 14(6):433-45. PubMed ID: 1363346
    [TBL] [Abstract][Full Text] [Related]  

  • 63. HER-2/neu genotype of breast cancer may change in bone metastasis.
    Lôrincz T; Tóth J; Badalian G; Tímár J; Szendrôi M
    Pathol Oncol Res; 2006; 12(3):149-52. PubMed ID: 16998594
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Identification of differentially expressed genes associated with HER-2/neu overexpression in human breast cancer cells.
    Oh JJ; Grosshans DR; Wong SG; Slamon DJ
    Nucleic Acids Res; 1999 Oct; 27(20):4008-17. PubMed ID: 10497265
    [TBL] [Abstract][Full Text] [Related]  

  • 65. DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinoma.
    Feng Q; Deftereos G; Hawes SE; Stern JE; Willner JB; Swisher EM; Xi L; Drescher C; Urban N; Kiviat N
    Gynecol Oncol; 2008 Nov; 111(2):320-9. PubMed ID: 18757082
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy.
    Yamashita S; Hattori N; Fujii S; Yamaguchi T; Takahashi M; Hozumi Y; Kogawa T; El-Omar O; Liu YY; Arai N; Mori A; Higashimoto H; Ushijima T; Mukai H
    Sci Rep; 2020 Sep; 10(1):15530. PubMed ID: 32968149
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bilateral synchronous breast cancer and HER-2/neu overexpression.
    Safal M; Lower EE; Hasselgren PO; Hungness ES; Gazder P; Aron B; Shaughnessy EA; Yassin R
    Breast Cancer Res Treat; 2002 Apr; 72(3):195-201. PubMed ID: 12058961
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases.
    Wu JM; Fackler MJ; Halushka MK; Molavi DW; Taylor ME; Teo WW; Griffin C; Fetting J; Davidson NE; De Marzo AM; Hicks JL; Chitale D; Ladanyi M; Sukumar S; Argani P
    Clin Cancer Res; 2008 Apr; 14(7):1938-46. PubMed ID: 18381931
    [TBL] [Abstract][Full Text] [Related]  

  • 69. DNA methylation marker to estimate the breast cancer cell fraction in DNA samples.
    Ishihara H; Yamashita S; Fujii S; Tanabe K; Mukai H; Ushijima T
    Med Oncol; 2018 Sep; 35(11):147. PubMed ID: 30218172
    [TBL] [Abstract][Full Text] [Related]  

  • 70. HER-2/neu, c-Myc and cyclin-A in human breast cancer.
    Tommasi S; Giannella C; Mangia A; Primavera A; Paradiso A; Schittulli F
    Int J Oncol; 1996 Jul; 9(1):111-5. PubMed ID: 21541489
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chemo brain or tumor brain - that is the question: the presence of extracranial tumors profoundly affects molecular processes in the prefrontal cortex of TumorGraft mice.
    Kovalchuk A; Ilnytskyy Y; Rodriguez-Juarez R; Shpyleva S; Melnyk S; Pogribny I; Katz A; Sidransky D; Kovalchuk O; Kolb B
    Aging (Albany NY); 2017 Jul; 9(7):1660-1676. PubMed ID: 28758896
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Breast Cancer and Her-2/Neu.
    Sherwood R
    EJIFCC; 2005 May; 16(2):46-47. PubMed ID: 29942236
    [No Abstract]   [Full Text] [Related]  

  • 73. HER-2/neu Testing in Breast Cancer.
    Wiktor A; Linden MD; Van Dyke DL
    J Assoc Genet Technol; 2003; 29(4):152-155. PubMed ID: 15213413
    [No Abstract]   [Full Text] [Related]  

  • 74. Your DNA May Appear Older Than You Think.
    Christensen BC
    J Natl Cancer Inst; 2019 Oct; 111(10):1007-1008. PubMed ID: 30794313
    [No Abstract]   [Full Text] [Related]  

  • 75. Correction: Comparison of the Prognostic Utility of Diverse Molecular Data among lncRNA, DNA Methylation, microRNA and mRNA across Five Human Cancers.
    Xu L; Fengji L; Changning L; Liangcai Z; Yinghui L; Yu L; Shanguang C; Jianghui X
    PLoS One; 2016; 11(3):e0152631. PubMed ID: 27010936
    [No Abstract]   [Full Text] [Related]  

  • 76. Pathological complete response of HER2-positive breast cancer to trastuzumab and chemotherapy can be predicted by HSD17B4 methylation.
    Fujii S; Yamashita S; Yamaguchi T; Takahashi M; Hozumi Y; Ushijima T; Mukai H
    Oncotarget; 2017 Mar; 8(12):19039-19048. PubMed ID: 28186977
    [TBL] [Abstract][Full Text] [Related]  

  • 77. HSD17B4 overexpression, an independent biomarker of poor patient outcome in prostate cancer.
    Rasiah KK; Gardiner-Garden M; Padilla EJ; Möller G; Kench JG; Alles MC; Eggleton SA; Stricker PD; Adamski J; Sutherland RL; Henshall SM; Hayes VM
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):89-96. PubMed ID: 19100308
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Alcohol and DNA Methylation: An Epigenome-Wide Association Study in Blood and Normal Breast Tissue.
    Wilson LE; Xu Z; Harlid S; White AJ; Troester MA; Sandler DP; Taylor JA
    Am J Epidemiol; 2019 Jun; 188(6):1055-1065. PubMed ID: 30938765
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Aberrant DNA Methylation, Expression, and Occurrence of Transcript Variants of the ABC Transporter
    Zappe K; Kopic A; Scheichel A; Schier AK; Schmidt LE; Borutzki Y; Miedl H; Schreiber M; Mendrina T; Pirker C; Pfeiler G; Hacker S; Haslik W; Pils D; Bileck A; Gerner C; Meier-Menches S; Heffeter P; Cichna-Markl M
    Cells; 2023 May; 12(11):. PubMed ID: 37296582
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The association between
    Li J; Zhou X; Li L; Ji L; Li J; Qu Y; Wang Z; Zhao Y; Zhang J; Liang F; Liu J; Gu W; Yang R; Ma F; Dai L
    Front Oncol; 2023; 13():1148635. PubMed ID: 37274256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.